Compass Therapeutics Q3 EPS $(0.15) Misses $(0.13) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 87.5 percent decrease over losses of $(0.08) per share
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 87.5 percent decrease over losses of $(0.08) per share from the same period last year.
